{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:51:56Z","timestamp":1780321916466,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11154-011-9164-6","type":"journal-article","created":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T12:22:29Z","timestamp":1300450949000},"page":"21-25","source":"Crossref","is-referenced-by-count":19,"title":["Primary aldosteronism, diagnosis and treatment in Japan"],"prefix":"10.1007","volume":"12","author":[{"given":"Yoshiyu","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehoro","family":"Karashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,19]]},"reference":[{"key":"9164_CR1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1291\/hypres.27.781","volume":"27","author":"Y Takeda","year":"2004","unstructured":"Takeda Y. Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist. Hypertens Res. 2004;27:781\u20139.","journal-title":"Hypertens Res"},{"key":"9164_CR2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1291\/hypres.24.469","volume":"24","author":"Y Takeda","year":"2001","unstructured":"Takeda Y. Genetic alterations in patients with primary aldosteronism. Hypertens Res. 2001;24:469\u201374.","journal-title":"Hypertens Res"},{"key":"9164_CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol. 2007;66:607\u201318.","journal-title":"Clin Endocrinol"},{"key":"9164_CR4","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW. Presidential address. Part I. Painting background. Part II. Primary aldosteronism, a new clinicalsyndrome. J Lab Clin Med. 1955;45:3\u201317.","journal-title":"J Lab Clin Med"},{"key":"9164_CR5","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"9164_CR6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/hr.2008.13","volume":"32","author":"T Ogihara","year":"2009","unstructured":"Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaji J, Horiuchi M, et al. The Japanese society of hupertension guidelines for the manegement of hypertension (JSH2009) Chapter 12. Secondary hypertension. Hypertens Res. 2009;32:78\u201390.","journal-title":"Hypertens Res"},{"key":"9164_CR7","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","volume":"88","author":"A Tanabe","year":"2003","unstructured":"Tanabe A, Naruse M, Takagi S, Tsuxhiya K, Imaki T, Takano K. Variability in the renin\/aldosterone profile under random and standard sampling conditions in primary aldosteronism. J Clin Endocrinol Metab. 2003;88:2489\u201394.","journal-title":"J Clin Endocrinol Metab"},{"key":"9164_CR8","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-032179","volume":"89","author":"O Olivieri","year":"2004","unstructured":"Olivieri O, Ciacciarelli A, Signorelli D, Pizzolo F, Guarini P, Pavan C, et al. Aldosterone to renin ratio in a primary care setting: the Bussolengo Study. J Clin Endocrinol Metab. 2004;89:4221\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"9164_CR9","doi-asserted-by":"crossref","unstructured":"Rossi GP, Seccia TM, Palumbo G, Belfiore A, Bernini G, Caridi G, et al. Within-patient reproducibility of the aldosterone:renin ratio in primary aldosteronism. Hypertension 2010;5.","DOI":"10.1161\/HYPERTENSIONAHA.109.139832"},{"key":"9164_CR10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","volume":"50","author":"GP Rossi","year":"2007","unstructured":"Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension. 2007;50:424\u201331.","journal-title":"Hypertension"},{"key":"9164_CR11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1507\/endocrj.KR-105","volume":"54","author":"T Nishikawa","year":"2007","unstructured":"Nishikawa T, Saito J, Omura M. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endoceine J. 2007;54:487\u201395.","journal-title":"Endoceine J"},{"key":"9164_CR12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1291\/hypres.29.883","volume":"29","author":"M Omura","year":"2006","unstructured":"Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res. 2006;29:883\u20139.","journal-title":"Hypertens Res"},{"issue":"Suppl 4","key":"9164_CR13","first-page":"S446","volume":"27","author":"Y Takeda","year":"2009","unstructured":"Takeda Y, Yoneda T, Karashima S, Demura M, Hashimoto A, Mori S, et al. Rapid assay of cortisol during adrenal vein sampling is useful for the diagnosis of primary aldosteronism. J Hypertens. 2009;27 Suppl 4:S446.","journal-title":"J Hypertens"},{"key":"9164_CR14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-90-3-386","volume":"90","author":"MH Weinberger","year":"1979","unstructured":"Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, et al. Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med. 1979;90:386\u201395.","journal-title":"Ann Intern Med"},{"key":"9164_CR15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1291\/hypres.30.1083","volume":"30","author":"F Satoh","year":"2007","unstructured":"Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Akira Uruno A, et al. Localization of aldosterone-producing adrenocortical adenomas: Significance of adrenal venous sampling. Hypertens Res. 2007;30:1083\u201395.","journal-title":"Hypertens Res"},{"key":"9164_CR16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF, Stanson AW, Thompson GB, Grant CS, Farkey DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136:1227\u201335.","journal-title":"Surgery"},{"key":"9164_CR17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","volume":"53","author":"TM Seccia","year":"2009","unstructured":"Seccia TM, Miotto D, Toni RD, Pitter G, Mantero F, Pseeina AC, et al. Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism. Comparison of 3 different protocols. Hypertension. 2009;53:761\u20136.","journal-title":"Hypertension"},{"key":"9164_CR18","doi-asserted-by":"crossref","unstructured":"Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocrinol Metab. 2010; doi: 10.1210\/jc.2009-1763 .","DOI":"10.1210\/jc.2009-1763"},{"key":"9164_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008;168:80\u20135.","journal-title":"Arch Intern Med"},{"key":"9164_CR20","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006;295:2638\u201345.","journal-title":"JAMA"},{"key":"9164_CR21","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","volume":"94","author":"M Stowasser","year":"2009","unstructured":"Stowasser M. Update in primary aldosteronism. J Clin Endocrinol Metab. 2009;94:3623\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"9164_CR22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/en.2005-0765","volume":"147","author":"K Shigematsu","year":"2006","unstructured":"Shigematsu K, Kawai K, Sakai H, Nakashima O, Iguchi A, et al. Analysis of unilateral adrenal hyperplasia with primary aldosteronism from the aspect of messenger ribonucleic acid expression for steoridogenic enzymes: a comparative study with adrenal cortices adhering to aldosterone-producing adenoma. Endocrinology. 2006;147:999\u20132006.","journal-title":"Endocrinology"},{"key":"9164_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.ju.0000162045.68387.c3","volume":"174","author":"S Ishida","year":"2005","unstructured":"Ishida S, Ito A, Sakai K, Satoh M, Chiba Y, Sato F, et al. Laparoscopic partial versus total adrealectomy for aldosterone producing adenoma. J Urol. 2005;174:40\u20133.","journal-title":"J Urol"},{"key":"9164_CR24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1464-410X.2009.08523.x","volume":"104","author":"CH Liao","year":"2009","unstructured":"Liao CH, Chung SD, Lai MK, Yu HJ, Chueh SC. Laparoscopic simultaneous bilateral partial and total adrenalectomy: a longer follow-up. BJUI. 2009;104:1269\u201373.","journal-title":"BJUI"},{"key":"9164_CR25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/hr.2009.29","volume":"32","author":"Y Takeda","year":"2009","unstructured":"Takeda Y. Effects of wplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension. Hypertens Res. 2009;32:321\u20134.","journal-title":"Hypertens Res"},{"key":"9164_CR26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","volume":"9","author":"A Karagiannis","year":"2008","unstructured":"Karagiannis A, Tziomalos K, Papageorgiou A, Kakafika AI, Pagourelias ED, Anagnostis P, et al. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother. 2008;9:509\u201315.","journal-title":"Expert Opin Pharmacother"},{"key":"9164_CR27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","volume":"50","author":"C Catena","year":"2007","unstructured":"Catena C, Colussi GL, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, et al. Long-term cardiac effects of adrenalectomy or mineralocortiocid antagonists in patients with primary aldosteronism. Hypertension. 2007;50:911\u20138.","journal-title":"Hypertension"},{"key":"9164_CR28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/HJH.0b013e328325d861","volume":"27","author":"A Zhu","year":"2009","unstructured":"Zhu A, Yoneda T, Demura M, Karashima S, Usukura M, Yamagishi M, et al. Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats. J Hypertens. 2009;27:800\u20135.","journal-title":"J Hypertens"},{"key":"9164_CR29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejphar.2008.02.001","volume":"28","author":"O Akizuki","year":"2008","unstructured":"Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K, et al. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R. Eur J Pharmacol. 2008;28:424\u201334.","journal-title":"Eur J Pharmacol"},{"key":"9164_CR30","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.1097\/01.fjc.0000197539.12685.f5","volume":"47","author":"K Imagawa","year":"2006","unstructured":"Imagawa K, Okayama S, Takaoka M, Kawata H, Naya N, Nakajima T, et al. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells. J Cardiovasc Pharmacol. 2006;47:13313\u20138.","journal-title":"J Cardiovasc Pharmacol"},{"key":"9164_CR31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","volume":"51","author":"JD Dietz","year":"2008","unstructured":"Dietz JD, Du S, Bolten CW, Payne MA, Xia C, Blinn JR, et al. A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. Hypertension. 2008;51:742\u20138.","journal-title":"Hypertension"},{"key":"9164_CR32","first-page":"265","volume":"1","author":"GT Griffing","year":"1985","unstructured":"Griffing GT, Melby JC. The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic hyperaldosteronism. J Clin Hypetens. 1985;1:265\u201376.","journal-title":"J Clin Hypetens"},{"key":"9164_CR33","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","volume":"94","author":"N Sukor","year":"2009","unstructured":"Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab. 2009;94:2437\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"9164_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1677\/JOE-07-0037","volume":"195","author":"P Ye","year":"2007","unstructured":"Ye P, Mariniello B, Mantero F, Shibata H, Rainey WE. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. J Endocrinol. 2007;195:39\u201348.","journal-title":"J Endocrinol"},{"key":"9164_CR35","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/jc.2006-2338","volume":"92","author":"HW Chang","year":"2007","unstructured":"Chang HW, Chu TS, Huang HY, Chueh SC, Wu VC, et al. Down-regulation of D2 dopamine receptor and increased protein kinase C\u03bc phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction. J Clin Endocrinol Metab. 2007;92:1863\u201370.","journal-title":"J Clin Endocrinol Metab"},{"key":"9164_CR36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2265.2005.02258.x","volume":"62","author":"Y Takeda","year":"2005","unstructured":"Takeda Y, Usukura M, Yoneda T, Oda N, Ito Y, Mabuchi H. The expression of messenger RNA of ADP-ribosyl cyclase in aldosterone-producing adenoma. Clin Endocrinol. 2005;62:504\u20138.","journal-title":"Clin Endocrinol"},{"key":"9164_CR37","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1073\/pnas.0712000105","volume":"105","author":"LA Davies","year":"2008","unstructured":"Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, et al. TASK channel deletion in mice causes primary aldosteronism. PNAS. 2008;105:2203\u20138.","journal-title":"PNAS"},{"key":"9164_CR38","doi-asserted-by":"crossref","unstructured":"Nogueira EF, Gerrt D, Mantero F, Mariniello B, Rainey WE. The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin Endocrinol 2009; (in press).","DOI":"10.1111\/j.1365-2265.2009.03738.x"},{"key":"9164_CR39","doi-asserted-by":"crossref","unstructured":"Kim MS, Kondo T, Takada I, Youn MY, Yamamoto Y, Takahashi S, et al. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009;461: doi: 10.1038 .","DOI":"10.1038\/nature08456"},{"key":"9164_CR40","doi-asserted-by":"crossref","unstructured":"Caroccia B, Fassina A, Seccia TM, Recarti C, Petrelli L, Bellori S, et al. Isolation of human adrenocortical aldosteorne-producing cells by a novel immunomagnetic beads method. Endocrinology 2009;151: doi: 10:1210 .","DOI":"10.1210\/en.2009-1243"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-011-9164-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-011-9164-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-011-9164-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T06:03:02Z","timestamp":1560060182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-011-9164-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9164"],"URL":"https:\/\/doi.org\/10.1007\/s11154-011-9164-6","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}